首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor
【2h】

Molecular Basis for Binding and Subtype Selectivity of 1,4-Benzodiazepine Antagonist Ligands of the Cholecystokinin Receptor

机译:胆囊收缩素受体的1,4-苯并二氮杂Ant拮抗剂配体的结合和亚型选择性的分子基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Allosteric binding pockets in peptide-binding G protein-coupled receptors create opportunities for the development of small molecule drugs with substantial benefits over orthosteric ligands. To gain insights into molecular determinants for this pocket within type 1 and 2 cholecystokinin receptors (CCK1R and CCK2R), we prepared a series of receptor constructs in which six distinct residues in TM2, -3, -6, and -7 were reversed. Two novel iodinated CCK1R- and CCK2R-selective 1,4-benzodiazepine antagonists, differing only in stereochemistry at C3, were used. When all six residues within CCK1R were mutated to corresponding CCK2R residues, benzodiazepine selectivity was reversed, yet peptide binding selectivity was unaffected. Detailed analysis, including observations of gain of function, demonstrated that residues 6.51, 6.52, and 7.39 were most important for binding the CCK1R-selective ligand, whereas residues 2.61 and 7.39 were most important for binding CCK2R-selective ligand, although the effect of substitution of residue 2.61 was likely indirect. Ligand-guided homology modeling was applied to wild type receptors and those reversing benzodiazepine binding selectivity. The models had high predictive power in enriching known receptor-selective ligands from related decoys, indicating a high degree of precision in pocket definition. The benzodiazepines docked in similar poses in both receptors, with C3 urea substituents pointing upward, whereas different stereochemistry at C3 directed the C5 phenyl rings and N1 methyl groups into opposite orientations. The geometry of the binding pockets and specific interactions predicted for ligand docking in these models provide a molecular framework for understanding ligand selectivity at these receptor subtypes. Furthermore, the strong predictive power of these models suggests their usefulness in the discovery of lead compounds and in drug development programs.
机译:肽结合G蛋白偶联受体中的变构结合口袋为小分子药物的开发创造了机会,而这些药物比正构配体具有更大的优势。为了深入了解1型和2型胆囊收缩素受体(CCK1R和CCK2R)中该口袋的分子决定因素,我们制备了一系列受体构建体,其中TM2,-3,-6和-7中的六个不同残基被颠倒了。使用了两种新颖的碘化CCK1R-和CCK2R选择性1,4,苯并二氮杂antagonist拮抗剂,它们在C3处的立体化学不同。当CCK1R中的所有六个残基都突变为相应的CCK2R残基时,苯二氮卓的选择性被逆转,而肽结合的选择性不受影响。详细分析(包括观察功能获得)表明,残基6.51、6.52和7.39对于结合CCK1R选择性配体最重要,而残基2.61和7.39对结合CCK2R选择性配体最重要,尽管取代的影响残留物2.61可能是间接的。配体引导的同源性建模应用于野生型受体和那些逆转苯二氮卓结合选择性的受体。该模型具有从相关诱饵中富集已知受体选择性配体的高预测能力,表明口袋定义的高度精确性。苯并二氮杂both在两个受体中以相似的姿势停靠,C3脲取代基指向上方,而C3处不同的立体化学则将C5苯环和N1甲基定向为相反的方向。在这些模型中预测的配体对接的结合口袋的几何形状和特异性相互作用为理解这些受体亚型的配体选择性提供了分子框架。此外,这些模型的强大预测能力表明它们在发现先导化合物和药物开发计划中很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号